12 Best Medical Stocks to Buy Now

Page 5 of 11

7. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 95

Johnson & Johnson (NYSE:JNJ) is one of the best medical stocks to buy now. In a report released on September 30, Matt Miksic from Barclays maintained a Hold rating on Johnson & Johnson (NYSE:JNJ) and set a price target of $176.00.

The rating update came after Johnson & Johnson (NYSE:JNJ) reported on September 29 the approval of TREMFYA for “pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children six years and older, weighing at least 40 kg”.

Management reported that the approval was based on the PROTOSTAR study that demonstrated pediatric patients receiving TREMFYA attained high levels of skin clearance vs. placebo at Week 16.

Johnson & Johnson (NYSE:JNJ) develops, manufactures, and sells products in the healthcare field. The company operates through two segments: Innovative Medicine and MedTech.

The MedTech segment includes an elaborate range of medical devices and products used in cardiovascular intervention, orthopedics, interventional solutions, surgery, and vision fields.

Page 5 of 11